Inversago Pharma Inc
$249,500.00 CAD
≈ 3 Canadians' average pay for a year
- Department
- National Research Council Canada
- Recipient country
- Canada
- Fiscal year
- 2021-2022
- Agreement period
- September 13, 2021 – June 3, 2022
- Reference
- nrc-cnrc:172-2021-2022-Q2-978964
Published purpose
The ultimate goal of the project is to develop new generation CB1 receptor blockers for clinical advancement applying key learnings from its CB1 receptor antagonist program.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.
Good value
Local impact
Needs context
Questionable
Success story
Wasteful
View official source record
Imported August 10, 2026 from open.canada.ca Grants & Contributions